SUFENTANIL CITRATE

Sufentanil Citrate Overview

Sufentanil citrate is a potent prescription synthetic opioid analgesic used within our Clinic (General Medicine), surgical suites, intensive care units, and labor units. It is used as an analgesic adjunct to general anesthesia or as a primary anesthetic agent during major surgical procedures, as well as for epidural pain management during labor and delivery.

What Is Sufentanil Citrate & How Does It Work?

Sufentanil citrate is a high-potency synthetic opioid analgesic that is approximately 5 to 10 times more potent than fentanyl and 500 to 1,000 times more potent than morphine.

It works by selectively binding to mu-opioid receptors within the brain, spinal cord, and peripheral nervous system. Activation of these receptors inhibits the release of neurotransmitters involved in transmitting pain signals, effectively blocking pain perception. When administered intravenously during surgery, it suppresses the body’s autonomic response to surgical stress (such as sudden increases in heart rate or blood pressure). When given epidurally, it provides targeted pain relief while allowing lower doses of local anesthetics to be used.

Is Sufentanil Citrate FDA Approved?

Yes, sufentanil citrate is officially approved by the United States Food and Drug Administration.

What Is Sufentanil Citrate Used For?

• Analgesic adjunct to nitrous oxide/oxygen general anesthesia during surgical procedures.
• Primary anesthetic agent for the induction and maintenance of anesthesia in major surgical procedures (such as open heart surgery).
• Epidural administration (alone or combined with bupivacaine) for acute pain management during labor and delivery or post-operative recovery.

Before Taking Sufentanil Citrate: Contraindications & Precautions

Healthcare providers perform comprehensive clinical evaluations prior to administering sufentanil citrate due to its high potency.

Who Should Not Receive Sufentanil Citrate?

• Patients with a known severe hypersensitivity or allergic reaction to sufentanil citrate or other synthetic opioid analgesics.
• Epidural administration is contraindicated in the presence of localized infection at the injection site or severe systemic bacteremia.

Sufentanil Citrate, Pregnancy & Fertility

• Intravenous sufentanil citrate during pregnancy should be used only if the potential benefit justifies the potential risk. It readily crosses the placenta and can cause respiratory depression in the newborn infant if administered near delivery.
• Epidural administration during labor is a standard clinical practice, provided the infant is monitored for respiratory depression upon birth.
• Sufentanil is excreted in human breast milk in small quantities; nursing mothers should consult their care team following surgical procedures requiring opioid anesthesia.
• Studies have not shown direct evidence of impaired human fertility from standard single-dose surgical exposures.

Tell Your Doctor Before Receiving Sufentanil Citrate

• Disclose any history of chronic obstructive pulmonary disease (COPD), asthma, or compromised respiratory reserve.
• Mention if you have severe liver or kidney impairment, which can delay drug metabolism and clearance.
• Inform your provider of any history of heart disease, severe bradycardia, or low blood pressure.
• Share if you have a personal or family history of substance use disorder or opioid intolerance.
• Provide a complete list of all current medications, especially central nervous system depressants, sedatives, or monoamine oxidase inhibitors (MAOIs).

Sufentanil Citrate Dosage & Administration

Sufentanil citrate is prepared and administered exclusively by qualified anesthesia professionals in monitored settings.

Standard Sufentanil Citrate Dosing

• Dosing is strictly individualized based on actual body weight, age, physical status, surgical procedure, and route of administration.
• For intravenous analgesic adjunct in surgery: Doses range from 0.5 to 1.0 micrograms per kilogram (mu g/kg) initially, with small incremental maintenance doses as needed.
• For primary anesthetic induction (major cardiac surgery): Doses range from 8 to 30 micrograms per kilogram (mu g/kg) administered with 100% oxygen.
• For epidural administration during labor: Standard single doses range from 10 to 15 micrograms (mu g), often combined with low-concentration local anesthetics like bupivacaine.

How Sufentanil Citrate Is Administered

• Administered via intravenous injection, continuous IV infusion, or lumbar epidural injection.
• Must be administered using dedicated infusion pumps or syringes under strict sterile conditions.
• Continuous vital sign tracking and emergency airway equipment (including opioid reversal agents) must be instantly accessible.

Sufentanil Citrate Clinical Efficacy & Research

Clinical trials demonstrate that sufentanil citrate provides profound hemodynamic stability during major surgical procedures. Studies confirm its high potency and rapid onset allow smooth control of heart rate and blood pressure responses to intense surgical stimuli compared to older opioids. Research also supports its epidural use, showing excellent labor pain relief with minimal motor block.

Sufentanil Citrate Side Effects & Safety Profile

As a potent mu-opioid agonist, sufentanil depresses respiratory drive and central nervous system activity.

• Addiction, Abuse, and Misuse: Sufentanil citrate exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death.
• Life-Threatening Respiratory Depression: Serious, life-threatening, or fatal respiratory depression may occur.
• Risks from Concomitant Use with Benzodiazepines or Other CNS Depressants: Concomitant use of opioids with benzodiazepines or other CNS depressants may result in profound sedation, respiratory depression, coma, and death.
• Neonatal Opioid Withdrawal Syndrome: Prolonged use during pregnancy can result in neonatal opioid withdrawal syndrome.

Sufentanil Citrate Severe Warnings

Sufentanil Citrate Common Side Effects

• Dose-dependent respiratory depression.
• Mild to moderate decrease in blood pressure (hypotension).
• Slow heart rate (bradycardia).
• Nausea, vomiting, or dizziness upon emergence.
• Mild itching (pruritus), particularly following epidural administration.

Serious Sufentanil Citrate Adverse Events

• Severe respiratory depression or fatal respiratory arrest.
• Skeletal muscle rigidity, including chest wall rigidity.
• Severe hypotension, severe bradycardia, or cardiovascular collapse.
• Severe allergic reactions, including anaphylaxis.
• Serotonin syndrome when combined with serotonergic medications.

Managing Sufentanil Side Effects

Because sufentanil is administered in operating rooms and intensive care units, side effects are treated immediately. Respiratory depression is managed by adjusting mechanical ventilation or administering the opioid antagonist naloxone (Narcan). Chest wall rigidity is treated by administering rapid-acting neuromuscular blocking drugs and establishing mechanical ventilation. Bradycardia is managed with IV anticholinergics like atropine.

Interactions & What to Avoid

Combining sufentanil with other central nervous system depressants increases the risk of life-threatening toxicity.

Sufentanil Citrate Interactions

• Other central nervous system depressants (such as benzodiazepines, sedatives, muscle relaxants, or general anesthetics) enhance respiratory depression and deep sedation.
• Strong CYP3A4 inhibitors (such as ketoconazole, ritonavir, or erythromycin) can decrease sufentanil clearance, prolonging its effects.
• Monoamine oxidase inhibitors (MAOIs) taken within 14 days increase the risk of severe serotonin reaction or severe blood pressure fluctuations.

Food & Alcohol

• Patients undergoing procedures requiring anesthesia must strictly follow institutional fasting guidelines (nothing by mouth).
• Alcohol consumption before and immediately after surgery involving opioid anesthetics is strictly prohibited due to additive central nervous system depression.

Sufentanil Citrate Missed Dose, Overdose & Storage

Strict federal controlled substance regulations and hospital protocols govern the handling of sufentanil.

Missed Dose of Sufentanil Citrate

Sufentanil is administered on demand or as an infusion by healthcare providers during surgical or labor management, so missed dose scenarios do not apply.

Sufentanil Citrate Overdose & Emergency

An overdose leads to severe respiratory depression, pinpoint pupils, extreme muscle flaccidity, cold clammy skin, severe low blood pressure, and coma. Treatment requires immediate airway management, 100% oxygen delivery, mechanical ventilation, and slow intravenous administration of the opioid antagonist naloxone (Narcan).

How to Store Sufentanil Citrate

Stored in secure, locked controlled-substance storage areas in healthcare facilities at controlled room temperature between 20°C and 25°C (68°F and 77°F). Protect from light. Preservative-free formulations in single-dose containers must be used immediately after opening.

Sufentanil Citrate Patient Management & Monitoring

Patients receiving sufentanil are observed continuously by qualified healthcare professionals.

Tests Before Starting Sufentanil Citrate

• Review of medical history for pulmonary, cardiac, hepatic, or renal conditions.
• Baseline blood pressure, heart rate, oxygen saturation, and respiratory rate checks.

Monitoring During Sufentanil Citrate Routine

• Continuous tracking of oxygen saturation, capnography (exhaled carbon dioxide), and respiratory rate.
• Continuous electrocardiogram (ECG) and automated blood pressure monitoring.
• Continuous monitoring of sensory block level and sedation depth during epidural use.

Sufentanil Citrate Do’s and Don’ts

• Do report any sudden difficulty breathing, intense itching, or severe nausea to your nursing team.
• Do remain in bed after receiving epidural or IV pain relief until cleared by your medical team.
• Don’t attempt to stand or walk unassisted until sensation and motor strength have fully returned.
• Don’t consume alcohol, take sleeping pills, or drive for at least 24 hours after receiving surgical anesthesia.

Frequently Asked Questions

References

• U.S. FDA – Sufenta (sufentanil citrate) prescribing information
• U.S. FDA Drugs@FDA – Drug approval overview
• American Society of Anesthesiologists (ASA) – Practice Guidelines for Pain Management

Legal Disclaimer

The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.